[Form 4] IBEX Ltd Insider Trading Activity

Rhea-AI Filing Summary

IBEX Ltd insider Christina Alice Trofimuk-O'Connor, identified as the company's Chief Legal Officer and a director, reported a sale of 366 common shares on 08/26/2025 at $29.13 per share. After the transaction she beneficially owned 12,571 shares directly. The filing states the sale was executed to satisfy tax withholding obligations arising from the vesting of restricted stock units and was not a discretionary trade. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person. All details above are taken directly from the submitted Form 4.

Positive

• Clear disclosure of the transaction date, price, number of shares sold, and post-transaction holdings
• Explanation provided that the sale was to cover tax withholding for vested restricted stock units and was not discretionary
• Form signed by an attorney-in-fact, indicating completed documentation

Negative

• Insider sale of 366 shares was reported, which may be perceived negatively by some investors despite the stated purpose

Insights

Securities Analyst

TL;DR: Routine tax-withholding sale of 366 shares; disclosure is timely and non-discretionary, so limited new information for valuation.

The filing documents a small, non-discretionary sale by a senior executive to cover tax withholding on vested restricted stock units. The proceeds per share were $29.13 and the post-transaction direct holding is 12,571 shares. Because the sale is explicitly tied to tax withholding rather than voluntary disposition, it carries limited informational content about the executive's view of company prospects. The transaction size is modest relative to typical executive holdings and contains no derivative activity or change in control.

Corporate Governance Expert

TL;DR: The Form 4 shows standard compliance with Section 16 reporting; transaction is administrative in nature, not a governance red flag.

The report identifies the reporting person as an officer and director and discloses the mechanics and purpose of the sale: tax withholding for RSU vesting. The inclusion of an explanation and attorney-in-fact signature indicates proper documentation. There is no indication of unusual trading patterns, related-party transactions, or material timing concerns in the filing itself.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Trofimuk-O'Connor Christina Alice

(Last) (First) (Middle)

C/O IBEX LIMITED

1717 PENNSYLVANIA AVENUE NW, SUITE 825

(Street)

WASHINGTON DC 20006

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IBEX Ltd [ IBEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/26/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	08/26/2025		S(1)		366	D	$29.13	12,571	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported on this Form 4 represent shares of Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units and do not represent discretionary trades by the Reporting Person.

Remarks:

	Lisa Lenstrohm, Attorney-in-Fact	09/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did IBEX insider Christina Trofimuk-O'Connor report on Form 4?

The filing reports a sale of 366 common shares of IBEX on 08/26/2025 at $29.13 per share and a post-transaction direct ownership of 12,571 shares.

Why were the shares sold according to the Form 4 for IBEX (IBEX)?

The Form 4 states the shares were sold to cover tax withholding obligations related to the vesting of restricted stock units and were not discretionary trades.

Does the Form 4 for IBEX include any derivative transactions?

No. The filing shows only a non-derivative sale of common shares; Table II for derivative securities contains no entries.

Who signed the Form 4 for IBEX on behalf of the reporting person?

The Form 4 was signed by Lisa Lenstrohm, Attorney-in-Fact on 09/15/2025.

What is the reporting person’s role at IBEX according to the filing?

Christina Alice Trofimuk-O'Connor is reported as an Officer (Chief Legal Officer) and is indicated as a Director on the form.